| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CMPSCOMPASS Pathways plc | 701.88M | 7.31 | -3.18 | -6.31% | 0.21 | |||
| ATAIAtai Beckley N.V | 1.35B | 3.71 | -3.99 | -1.91% | -51.09% | -96.43% | 0.21 | |
| NEUPNeuphoria Therapeutics Inc. | 22.05M | 4.10 | -17.83 | -40.76% | -30.24% | 100% | 0.01 |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 7.79M | 18.17M | 3.95M | 717.53K | 45.13K | 0 | 277.89K | 0 | 0 | 23.95M |
| Revenue Growth % | 0.07% | 1.33% | -0.78% | -0.82% | -0.94% | -1% | - | -1% | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 1.69M | 0 | 671.42K | 992.56K | 1.01M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | 0.04% |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | -1.69M | 0 | -671.42K | -992.56K | 22.94M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | 0.96% |
| Gross Profit Growth % | - | - | - | - | - | - | 1% | - | -0.48% | 24.11% |
| Operating Expenses | 34.21M | 30.3M | 32.68M | 19.34M | 9.36M | 11.26M | 27.71M | 21.58M | 25.79M | 24.67M |
| OpEx % of Revenue | 4.39% | 1.67% | 8.27% | 26.96% | 207.29% | - | 99.71% | - | - | 1.03% |
| Selling, General & Admin | 10.05M | 6.44M | 6.11M | 6.94M | 3.72M | 5.53M | 10.84M | 8.35M | 11.69M | 10.88M |
| SG&A % of Revenue | 1.29% | 0.35% | 1.55% | 9.67% | 82.39% | - | 39.03% | - | - | 0.45% |
| Research & Development | 24.16M | 23.85M | 26.57M | 12.41M | 5.64M | 5.73M | 16.86M | 13.23M | 14.1M | 13.78M |
| R&D % of Revenue | 3.1% | 1.31% | 6.73% | 17.29% | 124.9% | - | 60.69% | - | - | 0.58% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -28.31M | -13.85M | -30.48M | -20.37M | -11.67M | -12.95M | -28.6M | -22.26M | -26.79M | -1.73M |
| Operating Margin % | -3.63% | -0.76% | -7.72% | -28.39% | -258.66% | - | -102.92% | - | - | -0.07% |
| Operating Income Growth % | 0.02% | 0.51% | -1.2% | 0.33% | 0.43% | -0.11% | -1.21% | 0.22% | -0.2% | 0.94% |
| EBITDA | -26.42M | -12.13M | -28.73M | -18.63M | -9.31M | -11.26M | -27.43M | -21.58M | -25.79M | -713.59K |
| EBITDA Margin % | -3.39% | -0.67% | -7.27% | -25.96% | -206.29% | - | -98.71% | - | - | -0.03% |
| EBITDA Growth % | 0.02% | 0.54% | -1.37% | 0.35% | 0.5% | -0.21% | -1.44% | 0.21% | -0.2% | 0.97% |
| D&A (Non-Cash Add-back) | 1.89M | 1.72M | 1.76M | 1.75M | 2.36M | 1.69M | 1.17M | 671.42K | 992.56K | 1.01M |
| EBIT | -24.46M | -11.14M | -32.72M | -14.8M | -6.89M | -8.32M | -29.2M | -22.22M | -23.32M | -1.28M |
| Net Interest Income | -498.64K | -589K | -1.09M | -1.46M | -1.2M | -1.07M | -11.7K | 323.16K | 220.1K | 166.5K |
| Interest Income | 915.95K | 925.02K | 422.32K | 197.95K | 39.13K | 4.29K | 6.79K | 323.16K | 220.1K | 166.5K |
| Interest Expense | 1.41M | 1.51M | 1.51M | 1.66M | 1.24M | 1.08M | 18.48K | 0 | 0 | 0 |
| Other Income/Expense | 2.16M | 918.89K | -4.05M | 2.95M | 3M | 3.19M | -642.61K | 39.87K | 3.46M | 445.56K |
| Pretax Income | -26.16M | -12.93M | -34.53M | -17.42M | -8.68M | -9.76M | -29.24M | -22.22M | -23.32M | -1.28M |
| Pretax Margin % | -3.36% | -0.71% | -8.74% | -24.28% | -192.29% | - | -105.23% | - | - | -0.05% |
| Income Tax | -9.98M | -6.28M | -8.13M | -6.78M | -3.05M | -1.11M | -6.31M | -568.89K | -130.73K | -716.9K |
| Effective Tax Rate % | 0.62% | 0.51% | 0.76% | 0.61% | 0.79% | 0.89% | 0.78% | 0.97% | 0.99% | 0.44% |
| Net Income | -16.18M | -6.65M | -26.4M | -10.6M | -6.89M | -8.65M | -22.94M | -21.65M | -23.19M | -565.77K |
| Net Margin % | -2.08% | -0.37% | -6.68% | -14.77% | -152.56% | - | -82.54% | - | - | -0.02% |
| Net Income Growth % | 0.13% | 0.59% | -2.97% | 0.6% | 0.35% | -0.26% | -1.65% | 0.06% | -0.07% | 0.98% |
| Net Income (Continuing) | -16.18M | -6.65M | -26.4M | -10.64M | -5.63M | -8.65M | -22.94M | -21.65M | -23.19M | -565.77K |
| Discontinued Operations | 0 | 0 | 0 | 42.19K | -1.26M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.33 | -0.13 | -0.46 | -0.16 | -0.11 | -0.10 | -0.13 | -0.17 | -0.10 | -0.23 |
| EPS Growth % | 0.11% | 0.61% | -2.54% | 0.65% | 0.31% | 0.09% | -0.3% | -0.31% | 0.41% | -1.3% |
| EPS (Basic) | -0.33 | -0.13 | -0.46 | -0.16 | -0.11 | -0.10 | -0.13 | -0.17 | -0.10 | -0.23 |
| Diluted Shares Outstanding | 38.1M | 40.11M | 40.19M | 43.44M | 45.41M | 65M | 112.78M | 122.39M | 149.8M | 1.62M |
| Basic Shares Outstanding | 38.1M | 40.11M | 40.19M | 43.44M | 45.41M | 65M | 112.78M | 122.39M | 149.8M | 1.62M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 43.38M | 41.86M | 26.39M | 17.6M | 5.73M | 23.24M | 28.76M | 8.87M | 13.19M | 15.04B |
| Cash & Short-Term Investments | 34.35M | 33.37M | 18.72M | 10.18M | 3.15M | 21.41M | 23.09M | 8.06M | 12.61M | 14.21B |
| Cash Only | 33.94M | 32.95M | 18.31M | 9.79M | 3.15M | 21.41M | 23.09M | 8.06M | 12.61M | 14.21B |
| Short-Term Investments | 410.73K | 422.65K | 404.02K | 385.19K | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 8.22M | 7.6M | 523.5K | 621.02K | 40.74K | 192.88K | 4.67M | 283.62K | 126.88K | 11.95M |
| Days Sales Outstanding | 385.05 | 152.73 | 48.38 | 315.91 | 329.46 | - | 6.13K | - | - | 182.06 |
| Inventory | 327.73K | 327.16K | 360.02K | 465.4K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 249 | 2.02K | 6.09M | 5.49M | 2.01M | 984.28K | 0 | 0 | 351 | 817.4M |
| Total Non-Current Assets | 22.35M | 22.74M | 21.41M | 19.98M | 17.95M | 17.53M | 16.17M | 10.52M | 14.46M | 13.55B |
| Property, Plant & Equipment | 2.12M | 2.01M | 2.02M | 1.76M | 724.9K | 654.37K | 464.01K | 221.66K | 218.97K | 105.38M |
| Fixed Asset Turnover | 3.68x | 9.03x | 1.96x | 0.41x | 0.06x | - | 0.60x | - | - | 0.23x |
| Goodwill | 7.95M | 9.42M | 9.16M | 8.94M | 8.84M | 9.32M | 8.85M | 5.79M | 8.69M | 8.64B |
| Intangible Assets | 12M | 11.01M | 9.95M | 9.02M | 8.08M | 7.47M | 6.77M | 4.08M | 5.47M | 4.8B |
| Long-Term Investments | 286.76K | 295.08K | 282.08K | 384K | 436.17K | 119K | 0 | 52.52K | 78.83K | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | -115.07K | -136.47K | -29.59K | 81.86K | 0 | -795 | 0 |
| Total Assets | 65.72M | 64.61M | 47.8M | 37.58M | 23.68M | 40.77M | 44.93M | 19.39M | 27.65M | 28.59B |
| Asset Turnover | 0.12x | 0.28x | 0.08x | 0.02x | 0.00x | - | 0.01x | - | - | 0.00x |
| Asset Growth % | 0.24% | -0.02% | -0.26% | -0.21% | -0.37% | 0.72% | 0.1% | -0.57% | 0.43% | 1033.02% |
| Total Current Liabilities | 8.5M | 10.67M | 9.76M | 9.67M | 5.68M | 1.77M | 2.31M | 1.82M | 3.83M | 4.22B |
| Accounts Payable | 1.97M | 1.46M | 2.65M | 842.3K | 866.78K | 772.93K | 1.07M | 958.06K | 2.24M | 1.15B |
| Days Payables Outstanding | - | - | - | - | - | 166.83 | - | 520.83 | 825.2 | 415.26K |
| Short-Term Debt | 2.89M | 6.53M | 4.29M | 5.92M | 3.56M | 0 | 0 | 97.9K | 33.12K | 116.31M |
| Deferred Revenue (Current) | 49.15K | 14.99K | 64.17K | 158.09K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.19M | 1.31M | 1.1M | 654.1K | 267.17K | 279.45K | 281.57K | 385.59K | 328.89K | 2.95B |
| Current Ratio | 5.10x | 3.92x | 2.70x | 1.82x | 1.01x | 13.10x | 12.46x | 4.87x | 3.45x | 3.56x |
| Quick Ratio | 5.06x | 3.89x | 2.67x | 1.77x | 1.01x | 13.10x | 12.46x | 4.87x | 3.45x | 3.56x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 25.53M | 22.85M | 25.58M | 15.52M | 9.28M | 3.23M | 3.47M | 2.92M | 6.33M | 5.37B |
| Long-Term Debt | 13.77M | 7.69M | 11.56M | 6.06M | 4.3M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 17.48K | 521.14K | 367.06K | 159.65K | 117.63K | 0 |
| Deferred Tax Liabilities | 3.78M | 3.67M | 2.21M | 2.06M | 1.51M | 1.38M | 1.24M | 1.11M | 963.54K | 495.11M |
| Other Non-Current Liabilities | 7.99M | 11.49M | 11.81M | 7.4M | 3.45M | 1.33M | 1.86M | 1.64M | 5.25M | 4.87B |
| Total Liabilities | 34.04M | 33.52M | 35.34M | 25.18M | 14.97M | 5.01M | 5.78M | 4.74M | 10.16M | 9.59B |
| Total Debt | 16.66M | 14.22M | 15.85M | 11.98M | 8.41M | 652.04K | 477.15K | 257.55K | 272.74K | 116.31M |
| Net Debt | -17.28M | -18.72M | -2.47M | 2.18M | 5.26M | -20.76M | -22.61M | -7.8M | -12.34M | -14.09B |
| Debt / Equity | 0.53x | 0.46x | 1.27x | 0.97x | 0.96x | 0.02x | 0.01x | 0.02x | 0.02x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -20.01x | -9.14x | -20.17x | -12.30x | -9.43x | -12.02x | -1547.24x | - | - | - |
| Total Equity | 31.69M | 31.09M | 12.46M | 12.39M | 8.71M | 35.76M | 39.15M | 14.65M | 17.49M | 19B |
| Equity Growth % | 0.29% | -0.02% | -0.6% | -0.01% | -0.3% | 3.1% | 0.09% | -0.63% | 0.19% | 1085.48% |
| Book Value per Share | 0.83 | 0.77 | 0.31 | 0.29 | 0.19 | 0.55 | 0.35 | 0.12 | 0.12 | 11708.85 |
| Total Shareholders' Equity | 31.69M | 31.09M | 12.46M | 12.39M | 8.71M | 35.76M | 39.15M | 14.65M | 17.49M | 19B |
| Common Stock | 100.36M | 103.38M | 99.33M | 101.51M | 101.8M | 142.9M | 149.75M | 0 | 0 | 19K |
| Retained Earnings | -77.05M | -83.14M | -96.49M | -98.65M | -102.3M | -115.74M | -119.22M | -108.16M | -177.98M | -178.35B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 8.38M | 10.85M | 9.62M | 9.54M | 9.22M | 8.6M | 8.62M | 3.2M | -3.01M | -2.85B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -15.36M | -1.44M | -15.02M | -10.91M | -2.68M | -5.66M | -14.97M | -9.85M | -14.68M | 77.23M |
| Operating CF Margin % | -1.97% | -0.08% | -3.8% | -15.21% | -59.42% | - | -53.85% | - | - | 3.22% |
| Operating CF Growth % | -4.11% | 0.91% | -9.43% | 0.27% | 0.75% | -1.11% | -1.64% | 0.34% | -0.49% | 6.26% |
| Net Income | 0 | 0 | 0 | 0 | -4.89M | -6.53M | -14.97M | -14.38M | -15.49M | -369.63M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 1.68M | 1.28M | 763.17K | 446.09K | 662.99K | 662.89M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 38.03K | 983.01K | 1.95M | 0 | 814.81K | 163.77M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -468.43M |
| Other Non-Cash Items | -15.36M | -1.44M | -15.02M | -10.91M | -2.28M | -2.62M | 1.15M | 1.01M | -2.12M | 89.12M |
| Working Capital Changes | -1.45M | 970.52K | 63.96K | -480.02K | 2.77M | 1.23M | -3.85M | 3.08M | 1.46M | -496.83K |
| Change in Receivables | 0 | 0 | 0 | 0 | 2.71M | 1.52M | -4.01M | 2.78M | 299.2K | 114.94K |
| Change in Inventory | 0 | 0 | 0 | 0 | -19.44K | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 251.69K | 804.37K | -917.66K |
| Cash from Investing | 824.64K | 733.05K | 59.68K | 138.42K | -134.08K | -60.26K | 427.68K | 0 | 0 | 0 |
| Capital Expenditures | -146.9K | -190.2K | -358.11K | -69.28K | -5.29K | -1.1K | -1.06K | 0 | 0 | 0 |
| CapEx % of Revenue | 0.02% | 0.01% | 0.09% | 0.1% | 0.12% | - | 0% | - | - | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 971.53K | 923.25K | 417.79K | 207.71K | 221.76K | 29.85K | 129.06K | 0 | 0 | 0 |
| Cash from Financing | 24.79M | -1.6M | 1.94M | 3.05M | -3.68M | 23.71M | 18.57M | 2.6M | 15.11M | 1.53B |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | 0 | 0 | -294.4K | -226.68K | -312.17K | -3.94M | 0 | 5M | 1.53B |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -11.62M | -1.3M | -15.38M | -10.98M | -2.69M | -5.67M | -14.97M | -9.85M | -14.68M | 77.23M |
| FCF Margin % | -1.49% | -0.07% | -3.89% | -15.31% | -59.54% | - | -53.86% | - | - | 3.22% |
| FCF Growth % | -4.7% | 0.89% | -10.86% | 0.29% | 0.76% | -1.11% | -1.64% | 0.34% | -0.49% | 6.26% |
| FCF per Share | -0.30 | -0.03 | -0.38 | -0.25 | -0.06 | -0.09 | -0.13 | -0.08 | -0.10 | 47.59 |
| FCF Conversion (FCF/Net Income) | 0.95x | 0.22x | 0.57x | 1.03x | 0.39x | 0.66x | 0.65x | 0.45x | 0.63x | -136.50x |
| Interest Paid | 1.7M | 1.95M | 1.93M | 1.93M | 1.34M | 726.42K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 65.68K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -57.58% | -21.18% | -121.24% | -85.29% | -65.24% | -38.88% | -61.23% | -80.47% | -144.32% | -0.01% |
| Return on Invested Capital (ROIC) | -142.08% | -77.57% | -204.56% | -124.41% | -61.33% | -67.02% | -136.02% | -142.72% | -334.63% | -0.05% |
| Gross Margin | - | - | - | - | - | - | - | - | - | 95.76% |
| Net Margin | -207.75% | -36.58% | -668.33% | -1477.09% | -15255.78% | - | -8253.62% | - | - | -2.36% |
| Debt / Equity | 0.53x | 0.46x | 1.27x | 0.97x | 0.96x | 0.02x | 0.01x | 0.02x | 0.02x | 0.01x |
| Interest Coverage | -20.01x | -9.14x | -20.17x | -12.30x | -9.43x | -12.02x | -1547.24x | - | - | - |
| FCF Conversion | 0.95x | 0.22x | 0.57x | 1.03x | 0.39x | 0.66x | 0.65x | 0.45x | 0.63x | -136.50x |
| Revenue Growth | 6.66% | 133.25% | -78.26% | -81.83% | -93.71% | -100% | - | -100% | - | - |
Neuphoria Therapeutics Inc. (NEUP) reported $9.3M in revenue for fiscal year 2025. This represents a 74% increase from $5.3M in 2012.
Neuphoria Therapeutics Inc. (NEUP) grew revenue by 0.0% over the past year. Growth has been modest.
Neuphoria Therapeutics Inc. (NEUP) reported a net loss of $378.3M for fiscal year 2025.
Neuphoria Therapeutics Inc. (NEUP) has a return on equity (ROE) of -0.0%. Negative ROE indicates the company is unprofitable.
Neuphoria Therapeutics Inc. (NEUP) generated $77.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.